Cost analysis and cost-effectiveness of open versus laparoscopic versus robot-assisted versus transanal total mesorectal excision in patients with rectal cancer: a protocol for a systematic review.

Journal: BMJ open
Published Date:

Abstract

INTRODUCTION: Nowadays, most rectal tumours are treated open or minimally invasive, using laparoscopic, robot-assisted or transanal total mesorectal excision. However, insight into the total costs of these techniques is limited. Since all three techniques are currently being performed, including cost considerations in the choice of treatment technique may significantly impact future healthcare costs. Therefore, this systematic review aims to provide an overview of evidence regarding costs in patients with rectal cancer following open, laparoscopic, robot-assisted and transanal total mesorectal excision.

Authors

  • Ritchie T J Geitenbeek
    Department of Surgery, Meander MC, Amersfoort, The Netherlands rtj.geitenbeek@meandermc.nl.
  • Thijs A Burghgraef
    Department of Surgery, Meander Medical Center, Maatweg 3, 3813 TZ, Amersfoort, the Netherlands. ta.burghgraef@umcg.nl.
  • Mark Broekman
    Department of Surgery, University Medical Centre Groningen, Groningen, The Netherlands.
  • Bram P A Schop
    Department of Surgery, University Medical Centre Groningen, Groningen, The Netherlands.
  • Tom G F Lieverse
    Department of Surgery, University Medical Centre Groningen, Groningen, The Netherlands.
  • Roel Hompes
    Department of Surgery, University Medical Center Amsterdam, Location AMC, Amsterdam, the Netherlands.
  • Klaas Havenga
    Department of Surgery, University Medical Centre Groningen, Groningen, The Netherlands.
  • Maarten Postma
    Department of Health Sciences, University Medical Centre Groningen, Groningen, The Netherlands.
  • Esther C J Consten
    Jan J van Iersel, Tim JC Paulides, Paul M Verheijen, Ivo AMJ Broeders, Esther CJ Consten, Meander Medical Centre, Department of Surgery, 3813 TZ Amersfoort, The Netherlands.